| Filed | Form | Description | |
|---|---|---|---|
| 12/16/24 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| 10/9/24 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| 7/11/24 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| 5/3/24 | SC 13G/A | AMENDMENT TO FORM SC 13G | → |
| 4/9/24 | SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | → |
| 4/3/24 | SC 13G/A | AMENDMENT NO. 3 TO SCHEDULE 13G | → |
| ↓ | |||
Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain.